ENVALITH
エステー株式会社 logo

S.T.CORPORATION

4951Prime MarketChemicals

エステー株式会社 logo
S.T.CORPORATION4951
Reference Indicators

Market Cap

350¥100M

P/E (Forecast)

P/B

0.9x

Dividend Yield (Forecast)

3.02%

ROE

4.9%

EV/EBITDA

6.9x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
45,46945,57644,47248,11448,492
Cost of Sales
27,66428,62128,05730,18530,247
Gross Profit
17,80416,95416,41417,92818,244
SG&A Expenses
14,55414,53815,07316,26916,257
Operating Income
3,2502,4161,3411,6581,986
Non-operating Income
366396645522471
Non-operating Expenses
13581579741
Ordinary Income
3,4812,7301,9302,0842,416
Extraordinary Income
5517791,758220
Extraordinary Losses
1,836417679129
Pre-tax Income
1,7002,7071,9333,7632,508
Income Taxes
490820536876776
Net Income
1,1091,8281,2742,8341,615
EBITDA
4,5443,8232,6253,1143,667
Gross Margin
39.2%37.2%36.9%37.3%37.6%
Operating Margin
7.1%5.3%3.0%3.4%4.1%
ROA
2.5%4.0%2.8%6.2%3.5%
ROE
3.5%5.7%3.9%8.6%4.9%